m*******s
发帖数: 469 | 1 【 以下文字转载自 Pharmaceutical 讨论区 】
发信人: mitguests (未名过客), 信区: Pharmaceutical
标 题: 两位Eli Lilly中国科学家被指控泄露5500万美元的商业秘密给中国
发信站: BBS 未名空间站 (Thu Oct 10 13:20:43 2013, 美东)
又一起窃取机密 泄密案件
来源: lilipp 于 2013-10-09 17:21:46 [档案] [博客] [旧帖] [给我悄悄话] 本文已
被阅读：571次 字体：调大/调小/重置 | 加入书签 | 打印 | 所有跟帖 | 加跟贴 |
查看当前最热讨论主题
证券时报网（www.stcn.com）10月09日讯
根据美国媒体wishtv 10月8日的报道，联邦法庭周二晚些时候的公开文件显示，两位前
礼来科学家被指控泄露5500万美元的商业秘密给其直接竞争对手中国江苏恒瑞医药制药
公司。
报道称，Guoqing Cao和Shuyu Li于8月14日被起诉，两位均出生于中国，但几年前成为
美国公民。根据法庭文件，曹和李居住在卡梅尔时，将有关糖尿病、心脏病和癌症药物
发展专有信息的商业机密复制到外部硬盘。公诉人指控说，两人之间以及另一位未被起
诉的礼来前雇员曾多次互通涉及商业机密的邮件，而这位雇员现任恒瑞医药代表，在起
诉书中并未指名道姓。
美国地方法院法官Mark Dinsmore周二晚裁定，两人应关押在马里恩县监狱直到受审，
并不得保释。检察官寻求这样的裁决是认为这两人如果被释放，有可能潜逃至中国。
报道中，美国律师称两位被告是否有事实上的获利动机仍在调查之中。礼来公司研发部
高级副总裁William Heath给出的证词是，这些信息花费大约10年的研究，价值5500万
美元。而礼来的高级副总裁Michael Harrington则在声明中表示，这些前员工所偷窃的
机密信息与早期临床开发潜在的新药物有关，公司将积极采取一切法律手段来保护研究
成果。
针对这一事件，恒瑞医药（600276）10月9日晚间公告，公司未收到任何境内外司法机
关就上述事项的任何法律文件，公司在经营、研发活动中，一向遵守适用法律的要求，
不存在任何违反适用法律的行为。公司将聘请境内外律师，就上述传闻进行调查，并在
必要时配合有权司法机关的调查。
恒瑞医药董秘戴洪斌在电话中向记者表示，“目前并不清楚情况，需要到晚些时候联系
上美国方面才能了解”。（袁源）
——————————————————————————————————————
————————
http://business.sohu.com/20131009/n387828464.shtml
全景网10月9日讯 恒瑞医药（600276）周三晚间发布澄清公告，否认境内外媒报道的公
司获取价值5500万美元（折合3.3亿人民币）商业机密，称本公司将聘请境内外律师，
就有关传闻进行调查，并在必要时配合有权司法机关的调查。
近日，境内外有媒体报道称,据美国联邦法院
相关公司股票走势
恒瑞医药35.40-0.16-0.45%
公布的文件显示,两位前美国礼来制药公司(Eli Lilly)的科学家被控向恒瑞医药泄露价
值5500万美元的商业机密。相关报道还称，据美法院公布文件显示,两人将涉及糖尿病
、心脏病和癌症药物研发的专有信息拷贝到外部硬盘,而且两人曾多次发送涉及商业机
密的邮件。
恒瑞医药声明称，截止本公告日，公司未收到任何境内外司法机关就上述事项的任
何法律文件，而公司在经营、研发活动中一向遵守适用法律的要求，不存在任何违反适
用法律的行为。
Former Lilly scientists indicted for passing R&D secrets to Chinese
drugmaker
October 9, 2013 | By Tracy Staton
SHARE
TOOLS
Comment
Print
Contact Author
Reprint
Two former Eli Lilly ($LLY) scientists stand accused of passing laboratory
trade secrets to a Chinese drugmaker. Guoqing Cao and Shuyu "Dan" Li are
held without bail in Indiana, where they were indicted on charges of
stealing Lilly's research info to share with Shanghai-based Jiangsu Hengrui
Medicine Co.
Arrested Oct. 1, both men appeared in an Indianapolis court yesteday,
wearing black-and-white prison jumpsuits and manacles, the Indianapolis
Business Journal reports. During two-hour court proceedings, Assistant U.S.
Attorney Cynthia Ridgeway argued that if Cao and Li's actions "could be
wrapped up in one word, that word would be 'traitor.'" Both men are U.S.
citizens.
Li's attorney disputed Ridgeway's comments, saying that prosecutors had
failed to prove that the two men should be held in custody. He called the
government's case an "overreach" and asked for their release, saying they
would surrender their passports until the case is resolved. Magistrate Judge
Mark Dinsmore ordered that they be held until trial.
Lilly's global head of product development, Bill Heath, said the secrets Cao
and Li allegedly shared could help Hengrui copy Lilly's research. The
secrets involved early-stage research on cardiovascular disease, diabetes
and cancer, and are worth an estimated $55 million, the company said.
The indictment mentions a third person--Individual #1--who allegedly worked
with Cao and Li; that individual remains under investigation but has not
been arrested. Lilly worked with the government on the case, the IBJ says.
"Lilly will aggressively pursue every legal remedy to protect and safeguard
its scientific discoveries," Lilly General Counsel Michael Harrington said
in a statement.
Read more: Former Lilly scientists indicted for passing R&D secrets to
Chinese drugmaker - FiercePharma http://www.fiercepharma.com/story/former-lilly-scientists-indicted-passing-rd-secrets-chinese-drugmaker/2013-10-09#ixzz2hLAqkVbz
Subscribe at FiercePharma |
|
